Research work · 2015
Neuroendocrine Tumors, Version 1.2015
Matthew H. Kulke, Manisha H. Shah, Al B. Benson, Emily K. Bergsland, Jordan D. Berlin, Lawrence Scott Blaszkowsky, Lyska L. Emerson, Paul F. Engstrom, Paul Timothy Fanta, Thomas J. Giordano, Whitney Sears Goldner, Thorvardur Ragnar Halfdanarson, Martin J. Heslin, FOUAD R. KANDEEL, Pamela L. Kunz, Boris W. Kuvshinoff, Christopher Hanyoung Lieu, Jeffrey F. Moley, Gitonga Munene, Venu Gopal Pillarisetty
Journal of the National Comprehensive Cancer Network
Abstract
Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Neuroendocrine Tumors discuss the diagnosis and management of both sporadic and hereditary NETs. This selection from the guidelines focuses on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus.